380 related articles for article (PubMed ID: 33466394)
1. Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers.
Hwang K; Yoon JH; Lee JH; Lee S
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466394
[TBL] [Abstract][Full Text] [Related]
2. [Development of therapeutic antibodies for gastric and colorectal cancers].
Zhao TT; Fan NN; Lin L; Din Q; Zhan JB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 May; 41(3):345-52. PubMed ID: 22723173
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.
Yu M; Grady WM
Therap Adv Gastroenterol; 2012 Sep; 5(5):319-37. PubMed ID: 22973417
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
5. The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma.
Almquist DR; Ahn DH; Bekaii-Saab TS
BioDrugs; 2020 Jun; 34(3):349-362. PubMed ID: 32246441
[TBL] [Abstract][Full Text] [Related]
6. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
Shapira S; Lisiansky V; Arber N; Kraus S
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
[TBL] [Abstract][Full Text] [Related]
7. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer.
Lisby AN; Flickinger JC; Bashir B; Weindorfer M; Shelukar S; Crutcher M; Snook AE; Waldman SA
Expert Rev Precis Med Drug Dev; 2021; 6(2):117-129. PubMed ID: 34027103
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal model.
Wang W; Wu L; Zhang J; Wu H; Han E; Guo Q
Biochem Biophys Res Commun; 2017 May; 487(1):1-7. PubMed ID: 28042031
[TBL] [Abstract][Full Text] [Related]
9. Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors.
Tolba MF
Int J Cancer; 2020 Dec; 147(11):2996-3006. PubMed ID: 32415713
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects.
Makaremi S; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Sgambato A; Ghorbaninezhad F; Safarpour H; Argentiero A; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572263
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates.
Akbarzadeh Khiavi M; Safary A; Somi MH
Bioimpacts; 2019; 9(3):123-127. PubMed ID: 31508327
[TBL] [Abstract][Full Text] [Related]
12. AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression.
Wu Q; Yang ZF; Wang KJ; Feng XY; Lv ZJ; Li Y; Jian ZX
Am J Cancer Res; 2018; 8(2):266-279. PubMed ID: 29511597
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles for HMGA2 in colorectal cancer.
Wang X; Wang J; Wu J
Transl Oncol; 2021 Jan; 14(1):100894. PubMed ID: 33069103
[TBL] [Abstract][Full Text] [Related]
14. Development of monoclonal antibodies for the treatment of colorectal cancer.
Goodin S
Am J Health Syst Pharm; 2008 Jun; 65(11 Suppl 4):S3-7; quiz S22-4. PubMed ID: 18499888
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in colorectal cancer.
Agarwal P; Le DT; Boland PM
Adv Cancer Res; 2021; 151():137-196. PubMed ID: 34148613
[TBL] [Abstract][Full Text] [Related]
16. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
17. Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.
Ruzzo A; Graziano F; Canestrari E; Magnani M
Curr Cancer Drug Targets; 2010 Feb; 10(1):68-79. PubMed ID: 20088793
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines.
Azadi A; Golchini A; Delazar S; Abarghooi Kahaki F; Dehnavi SM; Payandeh Z; Eyvazi S
Biol Proced Online; 2021 Jul; 23(1):13. PubMed ID: 34193050
[TBL] [Abstract][Full Text] [Related]
19. New approaches in angiogenic targeting for colorectal cancer.
Prat A; Casado E; Cortés J
World J Gastroenterol; 2007 Nov; 13(44):5857-66. PubMed ID: 17990351
[TBL] [Abstract][Full Text] [Related]
20. The potential of monoclonal antibodies for colorectal cancer therapy.
Heidari F; Madadi S; Alizadeh N; Alimardani MH; Safari A; Armand MH; Pishgahzadeh E; Soleimani M
Med Oncol; 2023 Aug; 40(9):273. PubMed ID: 37603117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
